Entrar/Registro  
HOME SPANISH
 
Acta Médica del Centro
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Acta Médica del Centro >Year 2013, Issue 2


González VC, Ramos GHL
Menopause and its relationship with metabolic syndrome
Acta Med Cent 2013; 7 (2)

Language: Español
References: 35
Page:
PDF: 188.00 Kb.


Full text




ABSTRACT

The last few years have witnessed a significant growth in the life expectancy of Cuban women, reaching 80.02 years, a period of greater risk for the coexistence of the many factors that make up metabolic syndrome. This event, coupled with the fact that the average life of women is lengthened an average of 25 to 30 years after menopause, highlights the importance of providing women with the best quality of life possible. Villa Clara is one of the most aged provinces of the country and cardiovascular disease is the leading cause of death in women –it presents a decade earlier than in men for several reasons, including the possible protective effect exerted by estrogen on the cardiovascular system. Therefore, health professionals are required to remain updated in the skills needed to give them an optimal service. This article aims to provide an overview of the developments on the influence of the menopausal transition and the onset of metabolic syndrome in this period. It was concluded that the transition to menopause, and the hormonal profile that characterizes it, together with the aging phenomena, significantly increase the risk of metabolic syndrome. This syndrome, in turn, is a clinical condition that is associated with an increased risk of developing cardiovascular disease.


Key words: menopause, metabolic syndrome X, risk factors.


REFERENCIAS

  1. Canciano Chirino E, Ramos Junco I, Silva Vásquez N, Chirino Pacheco M, León López E. Metformín en el control clínico-metabólico de mujeres de edad mediana con hígado graso no alcohólico. Rev Cubana Obstetr Ginecol [Internet]. 2012 Oct-Dic [citado 16 Feb 2013];38(4):[aprox. 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0138-600X2012000400009&script=sci_arttex

  2. Fernández Milán A, Navarro Despaigne D. Adiposidad total, su distribución abdominal. Rev Cubana Obstetr Ginecol [Internet]. 2010 Jul–Sep [citado 16 Feb 2013];36(3):[aprox. 4 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0138-600X2010000300013&script=sci_arttex

  3. Carr MC. The Emergence of the Metabolic Syndrome with Menopause. J Clin Endoc Metab. 2003,88:2404-11.

  4. Kakafika Al, Liberopoulos EN, Karagliannis A, Athyros VG, Likhalidis DP. Dyslipidemia, hypercoagulability and the metabolic syndrome. Curr Vasc Pharmacol. 2006;4:175-83.

  5. Chu MC, Cushman M, Solomon R, Rogerio A, Lobo RA. Metabolic syndrome in postmenopausal women: the influence of oral or transdermal estradiol on inflammation and coagulation markers. Am J Obstet Gynecology. 2008;199:526.e1-7.

  6. Hu P, Greendale GA, Palla SL, Reboussin PA, Herrington DM, Barret-Connor E et al. The effects of hormone therapy on the marks of inflammation and endothelial function and plasma matrix metalloproteinase–9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial. Atherosclerosis. 2006;185:347-52.

  7. Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med. 2007 Sep;120 (9 Suppl 1):S10-6.

  8. Cho Geum J, Lee Jong H, Park Hyun T, Shin Jung H, Hong Soon C, Tak K, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause. 2008;15:524-9.

  9. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the Metabolic Syndrome. The Study of Women’s Health Across the Nation. Arch Intern Med. 2008;168:1568-75.

  10. Ferrer-Barriendos J. Guía de calidad de vida en la menopausia. Barcelona: Doctoractive S.L; 2007.

  11. Ferrer-Barriendos J. Cáncer de mama en la menopausia. Barcelona: Doctoractive S.L; 2008.

  12. Ferrer-Barriendos J. Calidad ósea en la menopausia. Barcelona: Doctoractive S.L; 2009.

  13. Deibert P, König D, Vitolins MZ, Landmann U, Ingrid Frey I, Zahradnik HP, et al. Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre-versus postmenopausal women. Nutr J. 2007 Oct 25;6:31.

  14. Navarro Despaigne D, Artiles Visbal L. La menopausia no es el fin de la vida. Rev Sexol Soc. 1996;2(5):35-9.

  15. Lozano E, Padrón Más J, Seuc A. Características generales y hormonas de la reproducción en la mujer posmenopáusica. Rev Cubana Endocrinol. 1995;6(1):29-36.

  16. Stanford JL, Hatge P, Brinton LA, Hoover RN, Brookmeyer R. Factors influencing the age of natural menopause. J Chronic Dis. 1987;40:995-1002.

  17. Santisteban Alba S. Atención integral a las mujeres de edad mediana. Rev Cubana Obstet Ginecol. 2011;37(2):251-70.

  18. Feliciano T. Menopausia y Riesgo Cardiovascular. REVCOG [Internet]. 2011 Abr-Jun [citado 16 Feb 2013];16(2):[aprox. 5 p.]. Disponible en: http://www.fecasog.org/.../index.php?...abril-junio-2011...2:revcog-2011

  19. Valero Lance P, Lázaro Romero C, García Bermejo P, Martínez Rocique M. Enfermedad Cardiovascular y Menopausia. Informes de la SVMFIC [Internet]. Valencia: Grupo de Atención a la Mujer de la Sociedad Valenciana de MF y C. Consultorio Auxiliar de Godelleta; 2011 [citado 16 Feb 2013]. Disponible en: http://www.revistafml.es/upload/ficheros/noticias/201104/04cardiovascular.pdf

  20. Fenochio-González F, Pichardo-Cuevas M, Linares Pérez M. Prevalencia del Síndrome Metabólico en mujeres postmenopáusicas con y sin tratamiento hormonal sustitutivo. Rev Invest Med Sur Mex. 2012;19(2):60-3.

  21. Kunstman S, Grazia R, Gainza D. Aterosclerosis en la mujer: factores de riesgo y prevención. Rev Chil Cardiol. 2012;31(2):142-7.

  22. Kunstmann S, Gainza D. Dislipidemia en la mujer: Diagnostico, clasificación y manejo. Rev Med Clín Condes. 2009;20:47-52.

  23. Gonzalo Martínez R, Rodrigo Alonso K, Victoria Novik A. Síndrome metabólico. Bases clínicas y fisiopatológicas para un enfoque terapéutico racional. Rev Méd Chile. 2009;137:685-94.

  24. Bahía L, Aguiar LG, Villela N, Bottino D, Godoy-Matos AF, Geloneze B. Relation ship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics. 2006;61:433-40.

  25. Aljada A, Mohanty P, Ghanim H, Abdo T, Tripathy D, Chaudhuri A, et al. Increase in intranuclear nuclear factor kappa B and decrease in inhibitor kappa B in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr. 2004;79:682-90.

  26. Yanes Quesada MA, Yanes Quesada M, Calderín Bouza R, Cruz Hernández J. Síndrome de insulinorresistencia, una amenaza para la salud. Rev Cubana Endocrinol [Internet]. 2008 Dic [citado 09 Feb 2011];19(3):[aprox. 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532008000300006&lng=es

  27. Lann D, Le Roith D. Insulin Resistance as the Underlying Cause for the Metabolic Syndrome. Med Clin N Am. 2007;91:1063-77.

  28. Estudio y tratamiento de mujeres en el climaterio y la posmenopausia. Punto de vista de la Asociación Mexicana para el Estudio del Climaterio en el año 2010. Ginecol Obstet Mex. 2010;78(8):423-40.

  29. Xing D, Nozell S, Chen YF. Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol. 2009;29:289-95.

  30. Matthews K, Sutton-Tyrrell K. ¿Qué hay de nuevo acerca de la menopausia y el riesgo cardiovascular? Rev Climaterio [Internet]. 2011 [citado 16 Feb 2013];14( 81):[aprox. 5 p.]. Disponible en: http://www.nietoeditores.com.mx/.../climaterio/Marzo-Abril2011/Climaterio%2081/Climaterio%2081.5%20QUE%20HAY.pdf

  31. Lobo R. Síndrome metabólico después de la menopausia y el papel de las hormonas. Rev Climaterio [Internet]. 2009 [citado 16 Feb 2013];13(73):1-10. Disponible en: http://www.nietoeditores.com.mx/.../1890-sindrome-metabolico-despues-de-la-menopausia-y-el-papel-de-las-hormonas.html

  32. Tabares-Trujillo M, Aguilera-Pérez J, Velázquez-Valassi B, Garza-Ríos P, Angulo-Torres L, García-Ruiz R. Síndrome metabólico en menopausia: implicaciones de la terapia hormonal. Perinatol Reprod Hum [Internet]. 2012 [citado 16 Feb 2013];26(1):25-29. Disponible en: http://www.medigraphic.com/pdfs/inper/ip-2012/ip121d.pdf

  33. Pacheco J. Simposio: Estrés oxidativo en la mujer climatérica. Rev Per Ginecol Obstet. 2010;56:85-6.

  34. Consenso de la Sociedad Internacional de Menopausia. Envejecimiento, menopausia, enfermedad cardiovascular y terapia de reemplazo hormonal. Rev Climaterio [Internet]. 2009 [citado 11 Mar 2013];13(73):11-23. Disponible en: http://www.nietoeditores.com.mx/.../climaterio/.../Climaterio%2073.3%20ENVEJECIMEINTO.pdf

  35. Miguel Soca PE. El síndrome metabólico: un alto riesgo para individuos Sedentarios. Temas de Salud. ACIMED [Internet]. 2009 [citado 11 Mar 2013];20(1) :[aprox. 8 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1024-94352009000800007






>Journals >Acta Médica del Centro >Year 2013, Issue 2
 

· Journal Index 
· Links 






       
Copyright 2019